Can an amino acid boost the power of ovarian cancer treatment?
Disease control
Not yet recruiting
This phase 1 trial is testing whether adding arginine, a common amino acid, to standard chemotherapy and immunotherapy can help people with platinum-resistant ovarian, fallopian tube, or peritoneal cancer. The study includes about 24 adults whose cancer has stopped responding to …
Phase 1 • Sponsor: Rebecca Arend • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC